Keyword: Vertex Pharmaceuticals
News
04.12.2023
-
UK’s RoslinCT, a cell and gene therapy contract development and manufacturing organization, will be part of the Vertex Pharmaceuticals global network producing the CRISPR...
News
05.09.2023
-
Last week, Lonza and Vertex Pharmaceuticals broke ground on a new US facility in Portsmouth, New Hampshire, to manufacture cell therapies for diabetes.
News
19.07.2022
-
US-based Vertex Pharmaceuticals has agreed to pay $320 million in cash to acquire ViaCyte, a compatriot private cellular therapy company specializing in a treatment for...
Strategy & Management
15.04.2020
- The pharmaceutical industry has been slowly, but surely, embracing continuous manufacturing (CM) over the past decade. In fact, most large pharma companies have invested in...
News
03.01.2013
- Rare diseases are a growing focus for drug companies, with prices for some treatments for ultra-rare conditions running into hundreds of thousands of dollars a year. The following...
News
03.01.2013
- The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...
News
02.01.2013
- U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...
News
02.11.2012
- Vertex Pharmaceuticals reported a net loss for the third quarter on Thursday with results hurt by fast-declining sales of its Incivek hepatitis C drug, as the company turned its...